dibromopropamidine diisethionate은 임신 중 안전한가요?

Related ingredients

Frequently asked questions

dibromopropamidine diisethionate은 임신 중 안전한가요?

No harmonised CLP classification or SCCS/CIR safety assessment was found for dibromopropamidine diisethionate (CAS 614-87-9); no reproductive or developmental toxicity studies for this substance were located in PubMed. The substance is used topically (ophthalmic/antiseptic formulations at ~0.15%), so systemic exposure from typical topical/ophthalmic use is expected to be low but measurable. Sources: ECHA substance page, PubChem, product/pharmacopoeia listings showing topical/ophthalmic use.

dibromopropamidine diisethionate은 모유 수유 중 안전한가요?

No evidence of reproductive or developmental hazard or mechanism specific to this compound was found. Because topical/ophthalmic use leads to low but measurable systemic exposure, a low exposure score is assigned for lactation; no data on milk transfer were located. Sources: PubChem entry, product/labeling references indicating topical ophthalmic use; no PubMed studies on lactation or milk transfer were found.

dibromopropamidine diisethionate은 아기 피부에 안전한가요?

No infant-specific reproductive or mechanistic evidence was found. The ingredient is used in topical/ophthalmic products (including products for children in some markets), and immature infant skin has higher per‑kg exposure; therefore exposure is scored one category higher than adult topical use. No data were found showing increased hazard or specific infant toxicity. Sources: product/medicinal listings showing pediatric topical/ophthalmic use and pharmacopoeial references; absence of reproductive/toxicity studies in PubMed.

VeriMom은 dibromopropamidine diisethionate을 어떻게 평가하나요?

VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 dibromopropamidine diisethionate을 93/100 (알려진 위험 없음)로 평가합니다.

임신 중 dibromopropamidine diisethionate 대체 안전 성분은?

유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.